Agios Pharmaceuticals at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Agios Pharmaceuticals brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 929. Its presence centres on sickle cell disease, where it supports a symposium on genetic therapies, activators and other new treatments. It also explains how the SCD Data Hub can serve as a concurrent control arm in a clinical trial.
| Organization | ASH 2026 Attendance |
|---|---|
Agios Pharmaceuticals Cambridge, MA | |
Commercial-stage biopharmaceutical company with roots in hematology, developing medicines for rare diseases. | Booth Exhibiting at Booth 929 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 7:00am–10:00am A Hematologist’s Guide to the Sickle Cell Disease Revolution: Genes, Activators, and Beyond Approved and emerging gene therapies and new pyruvate kinase activators for sickle cell disease, and how to match patients to each and refer them. |
Instantly find 20 buyers from Agios Pharmaceuticals
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction